MARIA VILLALOBOS: Open Payments
NPI 1356928790 · MURRAY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,071 in 21 payments from 9 companies in 2025. Trend: 2023 $243 · 2024 $838 · 2025 $1,071
Food & beverage: $1,071
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 6 | $306 |
| Boston Scientific Corporation | 1 | $147 |
| Ipsen Biopharmaceuticals, Inc | 1 | $146 |
| Mirum Pharmaceuticals, Inc. | 1 | $105 |
| ABBVIE INC. | 3 | $104 |
| Madrigal Pharmaceuticals | 3 | $92 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $87 |
| Hologic Sales and Service, LLC | 1 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $41 |
Products named: Livdelzi, TheraSphere Y90 Glass Microspheres 10 GBq, IQIRVO, Livmarli, REZDIFFRA, XIFAXAN, ELAHERE, APTIMA.
Industry payments across UT — which companies pay providers there.
